Meet Thomas Andersson, our new Senior Advisor Business Development. How could he be of help to your startup company?
— The most important thing I do is to get the startup companies rolling.
Thomas Andersson, the new Senior Advisor for Business Development at Oslo Cancer Cluster and Oslo Cancer Cluster Incubator, looks dead serious as he makes this statement, but immediately after he lets out a smile and elaborates:
— A company needs to be investible. An idea needs to attract investors.
A lifetime of experience
Thomas holds a Ph.D. in Physical Chemistry from Lund University in Sweden and has more than 30 years of experience from establishing, operating and funding start-ups in the life science field. He has a long background in business development in health tech startups, all the way back to the early 1980s.
— I’m that old! I went straight from my Ph.D. in biophysics into the problem-solving of business development.
In his career he has also taken on issues with patents and sales and he even bought a company that produced monoclonal antibodies with some friends and remodelled and sold it.
— What did you learn from this journey?
— I learned quite a lot, including the production business and the cell cultivation biotech business from the floor. I also learned how to lay out the production manufacturing facility.
See it like an investor
Thomas Andersson knows the biotech startup-scene from the investors’ point of view. He started to work at the tech transfer office of Karolinska Institutet in Sweden. It was called Karolinska Innovations back then, now it is known as KI Innovations.
— We raised a lot of money there, formed 45 companies as a group and we had a fantastic time!
After 8 years he was recruited to Lund and worked in Lund University Bio Science and tried to vacuum clean the whole university for life science innovation.
— And we did find a lot! In the end there were about 20 investment proposals and those ended up in 9 investments, of which we turned down 5 or 6. Two of them are now at the stock market.
In total, Thomas Andersson has been involved in starting about 20 companies, of which 5 survived and are now on the stock market.
Normally, it is said that only 1 in 30 biotech startups make it.
Here for you
— How did you end up here at Oslo Cancer Cluster?
— I have had my eyes on Oslo Cancer Cluster for a while. I have liked the ideas that the cluster stands for. And I wanted to do something new in the end of my career. That is why I am here as a senior advisor now. I like it here! I am working on very interesting projects and ideas.
Our new Senior Advisor Business Development is present in Oslo Cancer Cluster Incubator nearly every week although he still lives in Lund, Sweden, on a farm in the woods where he can be practical and hands-on with hardwood and fly fishing.
— My door is open to people in the cluster and incubator with projects and ideas. I have a network that can help them and I have the experience of how investors, scientists and other actors can value a company. And being a Swede in the Norwegian system; I am basically here also to encourage you to think differently.
Interested in more funding opportunities for your company?
Check out our Access to Capital-page.